Variable Interest Entity Narrative (Details) (USD $)	0 Months Ended	9 Months Ended
	Sep. 18, 2013	Sep. 30, 2014	Sep. 30, 2013	Nov. 30, 2007 sqft
Noncontrolling Interest [Line Items]
Business Divestiture, Sale Price	$ 10,500,000
Business Divestiture, Sale Price Allocation, Liabilities Assume	100,000
Proceeds from Divestiture of Businesses	6,000,000
Noncash or Part Noncash Divestiture, Amount of Consideration Received	2,400,000
Preferred Stock, Shares Outstanding	310,549
Preferred Stock, Value, Issued	2,100,000
Deemed dividend		0	9,540,000
Area of Real Estate Property				117,000
Cost of shared services	500,000
Biomedical Service
Noncontrolling Interest [Line Items]
Business Divestiture, Sale Price	10,500,000
Business Divestiture, Sale Price Allocation, Liabilities Assume	100,000
Proceeds from Divestiture of Businesses	6,000,000
Preferred Stock, Shares Outstanding	310,549
Preferred Stock, Value, Issued	2,100,000
Preferred Stock, Par or Stated Value Per Share	$ 6.72
Deemed dividend	9,500,000
Disposal Date	Sep. 18, 2013
Convertible Debt | Biomedical Service
Noncontrolling Interest [Line Items]
Noncash or Part Noncash Divestiture, Amount of Consideration Received	$ 2,400,000
N2 Biomedical LLC
Noncontrolling Interest [Line Items]
Area of Real Estate Property	27,000
Area of real estate property percent	19.00%
rent per square foot for first year	16.00
Rental rate increase on each annual anniversary	0.50